RGLS - regulusrx.com Book Valuation of Business

Public company logo of Regulus Therapeutics Inc. (RGLS)

Regulus Therapeutics (RGLS) is striving for monopoly pricing power by developing unique treatments for rare kidney diseases. The business model relies on outsourcing production and trials, which minimizes capital expenditures. The price indicator on this chart is fixed at 0.07. The development of innovative RNA therapies is accelerating through close collaboration with global pharma behemoths, creating powerful scientific and technological synergy.

regulusrx.com (RGLS) - Company Book Value from 07/04/2022 to 07/05/2025

Metric breakdowns and analytics for Regulus Therapeutics Inc. (RGLS)

- price and consensus price forecast:
Price Chart Regulus|RGLS - Price Target Chart
- market capitalization data:
Market Capitalization Regulus Therapeutics, Inc.|RGLS - Enterprise Value
- book capitalization data:
Equity per Share Regulus Therapeutics|RGLS - Company Book Value|Capitalization to Book Value Ratio regulusrx.com|RGLS - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Regulus Therapeutics|RGLS - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Regulus Therapeutics, Inc.|RGLS - Company Aggregate Debts|Debts to Book Value Regulus Therapeutics, Inc.
Summary company analysis:RGLS - Regulus
Flagship merchandise of Regulus Therapeutics, Inc.

Investors are assessing fundamental risks by analyzing the gap between total assets and liabilities to determine the business's real value. For Regulus Therapeutics (RGLS), which develops innovative RNA therapies for nephrology, changes in the company's accounting capitalization reflect net equity dynamics, allowing stakeholders to track the R&D burn rate and identify asset impairment risks prior to the publication of official financial statements.

Competing companies

TEM: Company Book Value|Qiagen N.V. - Company Book Value|ionispharma.com (IONS) - Book Valuation of Business|Book Capitalization Repligen (RGEN)|Accounting Capitalization RNA|Company Book Value CRISPR Therapeutics Corp CRSP|Accounting Capitalization GeneDx Corp (WGS)|Book Capitalization RARE (Ultragenyx Pharmaceutical)|beamtx.com - Book Capitalization|Company Book Value Sarepta (SRPT)|TWST - Accounting Value of Company|Book Capitalization TXG|Intellia Corp (NTLA) - Total Stockholders' Equity|Stoke Therapeutics - Book Capitalization|Book Value of Business biolifesolutions.com (BLFS)|Company Net Assets WVE|Book Capitalization MAZE (Maze Therapeutics, Inc.)|Company Book Value Sionna Pharma SION|PRME - Company Book Value|Taysha Gene Therapies - Company Net Assets|QURE: Book Capitalization|MeiraGTx - Company Book Value|Book Valuation of Business REGENXBIO Inc|SLDB - Company Net Assets|Accounting Value of Company Ocugen Pharma (OCGN)|Company Net Assets Pacific Biosciences|Total Net Assets benitec.com (BNTC)|Book Capitalization Design Therapeutics, Inc.|Accounting Value of Company Rocket Pharma RCKT|FDMT (4D Molecular Therapeutics Inc) - Book Capitalization|LXEO: Total Stockholders' Equity|Company Book Value korrobio.com KRRO|editasmedicine.com (EDIT) - Accounting Value of Company|SLN (Silence Therapeutics plc) - Book Capitalization|Book Capitalization PRQR|CDXS - Company Book Value|Net Asset Value Sangamo BioSciences (SGMO)|NAUT: Book Capitalization|MGX - Total Stockholders' Equity|Precision BioSciences - Company Net Assets|Generation Bio Co. (GBIO) - Book Capitalization|BOLD - Company Net Assets|Exicure (XCUR) - Total Net Assets|IMNN: Book Capitalization|Book Valuation of Business RXi Pharmaceuticals|Book Capitalization MBIO (Mustang Bio, Inc.)|Company Net Assets RNAZ (transcodetherapeutics.com)|Company Book Value BNGO|Applied DNA Corp - Book Valuation of Business|Company Book Value bluebird bio, Inc. (BLUE)|IPA - Accounting Value of Company|Book Capitalization OMGA (Omega Therapeutics, Inc.)|OMIC (Singular Genomics Systems, Inc.) - Book Value of Business|Company Book Value Syros|Company Book Value TBIO|TCON (TRACON Pharmaceuticals) - Company Book Value|Book Valuation of Business unitybiotechnology.com (UBX)